Thursday, July 3, 2008

Experts

NIR Spectroscopy & PAT

Contact Center Expert: Emil W. Ciurczak, Chief Technical Officer, Cadrai Group.

Emil W. Ciurczak has more than 35 years experience in pharmaceutical manufacturing, analytical R&D and regulatory compliance. He was a member of the validation subcommittee for the Pharmaceutical Advisory Committee for FDA and a consultant to the FDA. He is the co-author or co-editor for several texts, including "Handbook of Near-Infrared Analysis" (1st & 2nd eds.) and "Pharmaceutical and Medical Applications of Near-Infrared Spectroscopy." He is also Contributing Editor to Spectroscopy and is on the Editorial Boards for American Pharmaceutical Review, JPAT and Journal of NIRS. Ciurczak has a B.A. and M.S in Chemistry from Rutgers University and an M.S. in Chemistry from Seton Hall University. He holds patents for both instruments and software relating to spectroscopic analyses and has over 60 publications.


Choosing the right NIR instrument for the application
Which is the "best" near-infrared instrument on the market?
Category: NIR Spectroscopy and PAT

ROI from NIR
What would be the first application I should attempt with Near-Infrared?
Category: NIR Spectroscopy and PAT

The difference between a “monitor” and an “analyzer”
When measuring a process step, what is the difference between a "monitor" and an "analyzer?"
Category: NIR Spectroscopy and PAT